Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Automated cath labs to enhance cardiovascular care in India, says GlobalData

GE Healthcare has recently introduced its first made-in-India artificial intelligence (AI) enabled cath lab diagnostic imaging platform, the Optima IGS 320. This sophisticated interventional cardiology system will guide non-invasive cardiovascular procedures with better precision and versatility, says GlobalData, a leading data and analytics company. GlobalData forecasts the Indian cardiovascular devices market to grow at a […]
Read more

Accessibility challenges associated with mAbs in Japan likely to limit uptake of next-generation drugs for Alzheimer’s, says GlobalData

Monoclonal antibodies (mAbs), which are emerging as promising disease-modifying treatments for Alzheimer’s disease (AD), come with significant challenges associated with their accessibility. The technology to identify the pathological features of AD and safe administration of mAb therapies currently limit their access globally, with Japan being no exception. While the positive top-line results from Clarity AD, […]
Read more

AI-enabled made-in-India products to advance patient care in India, says GlobalData

With the rise of artificial intelligence (AI) and machine learning-focused healthtech startups in India, big companies such as Oracle Corp are looking for opportunities to invest and expand their footprint in the country. Against this backdrop, AI-enabled made-in-India products will offer advanced healthcare solutions and improve patient care in India, says GlobalData, a leading data, […]
Read more

Nanopore sequencing accelerates genomics for personalized and optimized treatment, says GlobalData

Genomics has been revolutionizing approaches to healthcare and precision medicine. The portability, scalability, and affordability of third-generation or long-read sequencing techniques such as nanopore sequencing have caused a dramatic shift in genomics to provide personalized medicine, accurate disease diagnosis, and disease prevention, says GlobalData, a leading data and analytics company. Kiran Raj, Practice Head of […]
Read more

Embraer seeks to expand into South Korea with slew of MoUs as it looks to offset recent issues with Brazil, says GlobalData

Following the news that Embraer has signed several memorandums of understanding with Aerospace Technology of Global, EM Korea Co. and Kencoa Aerospace in South Korea; Mathew George, Ph.D, Practice Head, Aerospace, Defense and Security at GlobalData, offers his view: “Embraer sees the value in expanding into Asia to help grow its business. This gains further […]
Read more

New NHMRC Centre to facilitate personalized breast cancer screening in Australia, says GlobalData

The University of Melbourne has recently launched My Breast cancer RISK Centre (MyBRISK), a new National Health and Medical Research Council Centre (NHMRC) for Research Excellence, to apply a holistic risk-based approach to breast cancer screening. This is expected to increase the diagnosis rate and facilitate early cancer detection and personalized screening, thereby reducing the […]
Read more

Healthcare firms discover ways to use virtual reality to treat neurological diseases, finds GlobalData

XRHealth, a US-based healthcare platform in the metaverse, has recently published a study that shows the potential of using virtual reality (VR) technologies in upper limb dysfunction in multiple sclerosis patients. With new technologies such as VR and augmented reality (AR) being implemented more often in healthcare industry, companies discover more ways new technologies can […]
Read more

APAC deal activity up by 2.5% YoY in Q1-Q3 2022 but suffers 22.9% decline in September, finds GlobalData

A total of 12,936 deals (mergers & acquisitions [M&A], private equity, and venture financing) were announced in the Asia-Pacific (APAC) region during Q1-Q3 2022, which is 2.5% growth compared to announcement of 12,618 deals during Q1-Q3 2021. However, September 2022 experienced a massive decline in deal activity, reveals GlobalData, a leading data and analytics company. […]
Read more

Protein alternatives likely to witness more demand, says GlobalData

Growing consumer awareness about cruelty-free products, venture capital (VC) investor interest, new business models, and novel source availability are driving the protein alternatives market globally. As these alternatives come close to conventional protein sources in terms of price, taste, and texture, we are likely to witness more demand in the future, making it an exciting […]
Read more
1 … 124 125 126 127 128 … 209